[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
Authors: N Just, O Duchamp, B Van Der Sanden, H Lahrech, N Guilbaud, P Genne, C Rémy, C Segebarth
Oncodesign; INSERM U594
Abstract: The response of gliomas to chemotherapy varies widely. Although some genetic alterations have been identified, there is no clear understanding of the mechanisms underlying the chemosensitivity of these tumors.
18 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260
Receive our general letter or our financial news!